Target intelligence / Profile preview

Misato family member 2, pseudogene (MSTO2P)

Target
MSTO2P
Molecular classification
Other (Pseudogene), Long non-coding RNA (lncRNA)
01

Overview

Misato family member 2, pseudogene (MSTO2P) is a human pseudogene encoding a long non-coding RNA (lncRNA), lacking protein-coding capability[1][3][7]. MSTO2P is overexpressed in several cancers including hepatocellular carcinoma, lung cancer, gastric cancer, and colorectal cancer, where it promotes cancer cell proliferation, invasion, and metastasis, possibly through regulation of the PI3K/AKT/mTOR signaling pathway and modulation of epithelial–mesenchymal transition[2][4][7]. MSTO2P can act as a molecular sponge for specific microRNAs (e.g., miR-128-3p), thereby exerting post-transcriptional regulation of other genes[4][9]. Though not a therapeutic target itself—since it is a pseudogene and not a receptor, enzyme, or similar molecule—MSTO2P is considered a biomarker for cancer prognosis and may play broader regulatory roles in cancer biology[2][4][7].

Other names
MSTO2
02

Mechanism of action

Not a direct therapeutic target; studies indicate it modulates cell phenotypes by functioning as a competing endogenous RNA (ceRNA) and by regulation of PI3K/AKT/mTOR signaling[2][9]

03

Biological functions

Regulation of cell proliferationApoptosisInvasionMetastasisRegulation of gene expressionRNA splicingEpithelial–mesenchymal transition
04

Disease associations

Cancer (Hepatocellular carcinoma, Lung cancer, Gastric cancer, Colorectal cancer)
05

Interacting drugs

Coptisine
06

Biomarkers

Overexpression is a prognostic biomarker in hepatocellular carcinoma and possibly other cancers[2]

Beyond the preview

Go deeper on Misato family member 2, pseudogene (MSTO2P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Misato family member 2, pseudogene (MSTO2P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call